FDA Inspection
STI Pharma LLCSTI Pharma LLC – FDA Inspection, Jul 21, 2016
Record Details
This FDA Inspection record concerns STI Pharma LLC, with an inspection on July 21, 2016, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- STI Pharma LLC
- Inspection Date
- July 21, 2016
- Product Type
- Drugs
View Company Profile
ID · 39eb4d74-f4e9-436e-b7c0-0029d7c31638
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 977705
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
1- 21 CFR 314.80(b)Failure to develop written procedures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of STI Pharma LLC
1| Date | Classification | Office | Project area |
|---|---|---|---|
| May 17, 2017 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for STI Pharma LLC
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.